Harald Reinhart - Sep 9, 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld, Attorney-in-Fact
Stock symbol
ZLAB
Transactions as of
Sep 9, 2021
Transactions value $
-$1,383,621
Form type
4
Date filed
9/10/2021, 04:17 PM
Previous filing
Sep 8, 2021
Next filing
Dec 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $30K +10K $3.00* 10K Sep 9, 2021 Direct F1
transaction ZLAB Ordinary Shares Sale -$375K -2.73K -27.31% $137.39* 7.27K Sep 9, 2021 Direct F1, F2
transaction ZLAB Ordinary Shares Sale -$124K -900 -12.38% $138.33* 6.37K Sep 9, 2021 Direct F1, F3
transaction ZLAB Ordinary Shares Sale -$79.2K -569 -8.93% $139.27* 5.8K Sep 9, 2021 Direct F1, F4
transaction ZLAB Ordinary Shares Sale -$113K -800 -13.79% $140.87* 5K Sep 9, 2021 Direct F1, F5
transaction ZLAB Ordinary Shares Sale -$99.3K -700 -14% $141.92* 4.3K Sep 9, 2021 Direct F1, F6
transaction ZLAB Ordinary Shares Sale -$229K -1.6K -37.21% $143.34* 2.7K Sep 9, 2021 Direct F1, F7
transaction ZLAB Ordinary Shares Sale -$115K -800 -29.63% $144.35* 1.9K Sep 9, 2021 Direct F1, F8
transaction ZLAB Ordinary Shares Sale -$204K -1.4K -73.68% $146.07* 500 Sep 9, 2021 Direct F1, F9
transaction ZLAB Ordinary Shares Sale -$73.3K -500 -100% $146.61* 0 Sep 9, 2021 Direct F1, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -10K -42.86% $0.00 13.3K Sep 9, 2021 Ordinary Shares 10K $3.00 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated June 2, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 Reflects a weighted average sale price of $137.39 per share, at prices ranging from $136.81 to $137.74 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 Reflects a weighted average sale price of $138.33 per share, at prices ranging from $137.89 to $138.67 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 Reflects a weighted average sale price of $139.27 per share, at prices ranging from $139.05 to $139.36 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 Reflects a weighted average sale price of $140.87 per share, at prices ranging from $140.47 to $141.26 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6 Reflects a weighted average sale price of $141.92 per share, at prices ranging from $141.47 to $142.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7 Reflects a weighted average sale price of $143.34 per share, at prices ranging from $142.81 to $143.72 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F8 Reflects a weighted average sale price of $144.35 per share, at prices ranging from $144.09 to $144.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F9 Reflects a weighted average sale price of $146.07 per share, at prices ranging from $145.49 to $146.46 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F10 Reflects a weighted average sale price of $146.61 per share, at prices ranging from $146.50 to $146.76 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F11 The options vest in equal annual installments over four years beginning on 5/12/2018, the first anniversary of the date of grant.